Clinical aspects and presumed etiology of multisystem inflammatory syndrome in children (MIS-C): A review.
Clin Epidemiol Glob Health
; 14: 100966, 2022.
Article
em En
| MEDLINE
| ID: mdl-35132389
ACE2, Angiotensin-Converting Enzyme-2; ADE, Antibody-Dependent Enhancement; AR, Allosomal Androgen Receptor; ARDS, Acute Respiratory Distress Syndrome; BNP, Brain Natriuretic Peptide; CDC, Centres for Disease Control and Prevention; CRP, C-reactive protein; ESR, Erythrocyte Sedimentation Rate; IVIG, Intravenous Immunoglobulin; KD, Kawasaki Disease; Kawasaki disease; LVEF, Left Ventricular Ejection Fraction; MIS-C; MIS-C, Multisystem Inflammatory Syndrome in Children; Macrophage and antibody-dependent enhancement (ADE); Multiorgan failure; NLRP3, NLR family Pyrin Domain Containing 3; PCAID, Pediatric COVID-19 Associated Inflammatory Disorder; PIMS-TS, Pediatric Inflammatory Multisystem Syndrome Temporally Associated; PPT, Prolonged Prothrombin Time; PTT, The Prothrombin Time Test; Pediatric patient; RT-PCR, Real Time- Polymerase Chain Reaction; SARS-COV-2, Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV-2; SHLH/MAS, Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome; TMPRSS2, Transmembrane Protease, Serine 2; TNP, Tumour Necrosis Factor; TSS, Toxic Shock Syndrome; TTSPs, Type II Transmembrane Serine Protease
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article